Valuation: Diaceutics PLC

Market Cap 122M 166M 143M 134M 230M 15.83B 234M 1.57B 616M 7.93B 622M 608M 26.35B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 114M 155M 134M 126M 215M 14.83B 219M 1.47B 577M 7.42B 582M 570M 24.67B EV / Sales 2026 *
2.45x
EV / Sales 2027 * 1.95x
Free-Float
71.95%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
3 months+19.76%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.67
Extreme 1.67
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 31/12/2023
Director of Finance/CFO - 17/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 30/09/2024
Director/Board Member 42 -
Director/Board Member 42 30/09/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 166M
+8.88%+47.73%+305.61%+1,366.10% 69.91B
+2.57%+3.25% - - 5.85B
-0.57%+5.58% - - 3.81B
+1.74%+4.64%+2.59%+39.21% 3.6B
+10.00%+12.95%+25.13%+138.85% 3.37B
-1.29%+3.22% - - 2.96B
+1.61%+2.81%-20.28%-22.23% 1.4B
+2.09%-1.06%-41.70%+46.16% 1.4B
Average +2.51%+9.21%+54.27%+313.62% 11.54B
Weighted average by Cap. +7.30%+37.31%+268.23%+1,206.67%

Financials

2026 *2027 *
Net sales 46.72M 63.29M 54.67M 51.37M 87.83M 6.05B 89.28M 602M 235M 3.03B 238M 232M 10.07B 56.34M 76.33M 65.93M 61.95M 106M 7.3B 108M 726M 284M 3.66B 287M 280M 12.15B
Net income -1.1M -1.49M -1.29M -1.21M -2.07M -143M -2.1M -14.17M -5.54M -71.36M -5.6M -5.47M -237M 1.5M 2.03M 1.76M 1.65M 2.82M 194M 2.87M 19.33M 7.56M 97.31M 7.63M 7.46M 323M
Net Debt -7.78M -10.54M -9.1M -8.55M -14.63M -1.01B -14.87M -100M -39.19M -505M -39.58M -38.72M -1.68B -12.1M -16.39M -14.15M -13.3M -22.74M -1.57B -23.12M -156M -60.94M -785M -61.53M -60.19M -2.61B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.440GBP
Average target price
2.130GBP
Spread / Average Target
+47.92%

Quarterly revenue - Rate of surprise